about
Epidemiology of hepatitis C virus infectionThe law (and politics) of safe injection facilities in the United States(-)-Epigallocatechin-3-Gallate Enhances Hepatitis C Virus Double-Stranded RNA Intermediates-Triggered Innate Immune Responses in Hepatocytes.Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived CellsImmune evasion versus recovery after acute hepatitis C virus infection from a shared sourceMethamphetamine enhances Hepatitis C virus replication in human hepatocytesUnderlying Pathophysiology of HCV Infection in HIV-Positive Drug UsersPrevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.SInjection Drug Use Is a Risk Factor for HCV Infection in Urban EgyptHepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infectionEmergence of Hepatitis C Virus Genotype 4: Phylogenetic Analysis Reveals Three Distinct Epidemiological ProfilesFactors associated with seroprevalence of hepatitis C among dentists at a large Brazilian cityThe exploding spark: workplace violence in an infectious disease hospital--a longitudinal studyHCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in ChinaMultiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China's HIV/HCV EpidemicsAnimal viral diseases and global change: bluetongue and West Nile fever as paradigmsIncidence of hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: a cohort studyRisk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans.High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US citiesSurvival of hepatitis C virus in syringes: implication for transmission among injection drug users.Inactivation and survival of hepatitis C virus on inanimate surfaces.Route of administration for illicit prescription opioids: a comparison of rural and urban drug users.Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes.Hepatitis C virus-specific T-cell immune responses in seronegative injection drug usersHepatitis C - contamination of toothbrushes: myth or reality?Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with menPsychiatric care of the patient with hepatitis C: a review of the literature.An overview of HCV molecular biology, replication and immune responses.Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?Hepatitis C virus genotypes in clinical specimens tested at a national reference testing laboratory in the United States.Characteristics of HCV co-infection among HIV infected individuals from an area with high risk of blood-borne infections in central China.Viral hepatitis and human immunodeficiency virus co-infections in AsiaTransition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop.Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran.Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. cityThe impact of illicit drug use and harmful drinking on quality of life among injection drug users at high risk for hepatitis C infection.HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes.Demographic characteristics and intravenous drug use among hepatitis C patients in the Kota Setar district, Kedah, Malaysia.Social networks and HCV viraemia in anti-HCV-positive rural drug users.
P2860
Q22305500-99F0C124-C2CE-44DE-AA65-C33E3252D603Q24657290-F965ED88-EEA1-4096-A89A-B2C9F4831E4DQ27346473-87A784C6-1719-46A2-8716-42D6B82E26CEQ27477544-148BB49C-65E6-463D-A92F-C5CDD443A1C9Q27485222-BA379997-660A-4F74-8B63-6875AE0C5F9EQ27488356-A75E36E9-CB9E-4737-9064-60CE2C93E865Q27489073-374ACE10-2766-4C17-AF41-BC984533C9A6Q27489610-15800EF2-C0DA-405B-87C1-D2F439E13363Q27489633-BC4145BC-C78C-4AF9-AD57-A40C2A0A4013Q27490176-0CA3BA82-8484-4EB3-A3CD-A04068D91259Q27490460-632A5452-24BF-4033-8CB7-B46424EE6B73Q27490798-61E8B1C9-EB42-46DD-959F-1FF95F062F73Q28385499-8F81F55F-B1EA-4961-BD0E-A7B115B9E400Q28477079-D73509CE-EE00-441B-B607-91E7BB1CB048Q28550924-D86DA030-53E2-4D7C-98DC-E467826F7657Q28728548-59288ED0-7C30-498B-B0BE-3F276B4002D3Q33811374-D2B6282A-BA1F-491E-A63A-3BC6AD06AF00Q33977173-AA7901F8-16AB-4DBE-9437-0A9482510D88Q33989662-A974E148-3735-40D7-8A8B-E6CA6653CF42Q34101237-DBF4BE70-0D63-42C4-8166-08049D30B13AQ34225779-1816CACB-455E-4274-8E61-D077BBDAA3A5Q34258184-EEA0C758-AEFD-4F55-B8E7-EE104251D2ADQ34258650-888DA5BB-E16E-4F00-AF0C-4216C68B320EQ34381567-7F71D8CC-5382-4CFD-9314-6A2E6E9322DAQ34557075-96A8625A-2A64-4535-9CD1-1D74A6E3EDD0Q34663297-1F456142-90C9-4FD3-B39C-DEA1BBF3838CQ34743058-8EDFFE3A-6EAF-4C25-BE30-8F6730697F7CQ34916120-A9247E03-6A3D-4261-8628-C020B760182AQ34946693-ABDE95D4-4DF0-47D6-A53E-8A6B3465FE49Q35139900-48AB276F-2C9F-4EE6-AFFC-A99B36B4FE92Q35141727-6459974A-4F89-482E-B105-8264B038E049Q35567832-08F7B9E2-DDF3-4080-B6F8-6130CBB3BE89Q35683199-AEA10CFC-40D4-46C0-BCFA-134E5CE16CF2Q35688936-386623D5-A301-4259-A64A-46CA90CFBCA3Q35819898-53214508-B700-44B3-8A01-1B34CD9149B4Q35946118-FFEE803E-DBE0-49C2-A73E-A3A25752C955Q35987538-5F2198D1-95A3-4F3D-903E-1B4359683748Q35988290-AC344095-B54E-4E15-A5E0-2BC644CACCB5Q36192394-D905F4DB-37E1-432A-BF9D-FD0C62EB7329Q36312926-2F597586-ED28-4D69-B5A7-2FC7303BE9B7
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prevention of spread of hepatitis C.
@ast
Prevention of spread of hepatitis C.
@en
Prevention of spread of hepatitis C.
@nl
type
label
Prevention of spread of hepatitis C.
@ast
Prevention of spread of hepatitis C.
@en
Prevention of spread of hepatitis C.
@nl
prefLabel
Prevention of spread of hepatitis C.
@ast
Prevention of spread of hepatitis C.
@en
Prevention of spread of hepatitis C.
@nl
P2860
P356
P1433
P1476
Prevention of spread of hepatitis C.
@en
P2093
Miriam J Alter
P2860
P356
10.1053/JHEP.2002.36389
P407
P433
P577
2002-11-01T00:00:00Z